ICD-10 Coding for Elevated Carcinoembryonic Antigen (CEA)(C18.9U, R97.0, R97.0B)
Learn about the ICD-10 coding for elevated carcinoembryonic antigen (CEA), including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Elevated Carcinoembryonic Antigen (CEA)
Key Information
Essential facts and insights aboutElevated Carcinoembryonic Antigen (CEA)
Alternative codes to consider when ruling out similar conditions
Use when colon cancer is confirmed and CEA is elevated.
Documentation & Coding Risks
Avoid these common issues when documenting Elevated Carcinoembryonic Antigen (CEA).
Not specifying CEA level
Impact
Clinical: Inadequate information for clinical decision-making., Regulatory: Non-compliance with documentation standards., Financial: Potential denial of claims due to insufficient documentation.
Mitigation
Always document CEA level with units, Include reference range
Using R97.0 as a primary diagnosis
Impact
Reimbursement: May lead to incorrect DRG assignment and reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Always use a definitive diagnosis as primary if available.
Primary Diagnosis Coding
Impact
Using R97.0 as a primary diagnosis when a malignancy is present.
Mitigation
Ensure primary diagnosis reflects the underlying malignancy.